K. Loeschke

2.4k total citations
78 papers, 1.8k citations indexed

About

K. Loeschke is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, K. Loeschke has authored 78 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Epidemiology and 16 papers in Surgery. Recurrent topics in K. Loeschke's work include Inflammatory Bowel Disease (13 papers), Ion Transport and Channel Regulation (11 papers) and Microscopic Colitis (8 papers). K. Loeschke is often cited by papers focused on Inflammatory Bowel Disease (13 papers), Ion Transport and Channel Regulation (11 papers) and Microscopic Colitis (8 papers). K. Loeschke collaborates with scholars based in Germany, United States and Italy. K. Loeschke's co-authors include Walter Heldwein, Reinhard Lorenz, C Folwaczny, B. Wiebecke, Folkhard Schmidt, Heinz Grunze, Martin Schaefer, Michael Soyka, Christian Weber and Thomas Strasser and has published in prestigious journals such as Gastroenterology, Hepatology and Gut.

In The Last Decade

K. Loeschke

73 papers receiving 1.6k citations

Peers

Countries citing papers authored by K. Loeschke

Since Specialization

Citations

This map shows the geographic impact of K. Loeschke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Loeschke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Loeschke more than expected).

Fields of papers citing papers by K. Loeschke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Loeschke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Loeschke. The network helps show where K. Loeschke may publish in the future.

Co-authorship network of co-authors of K. Loeschke

This figure shows the co-authorship network connecting the top 25 collaborators of K. Loeschke. A scholar is included among the top collaborators of K. Loeschke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Loeschke. K. Loeschke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Factors influencing long‐term changes in mental health after interferon‐alpha treatment of chronic hepatitis C 2009 ·Alimentary Pharmacology & Therapeutics ·Folkhard Schmidt, (unknown), (unknown), R. Lorenz, K. Loeschke, Michael Soyka, C Folwaczny, Martin Schaefer	13
2	Megaloblastäre Anämie durch Fehlernährung 2008 ·DMW - Deutsche Medizinische Wochenschrift ·M. Tschöp, C Folwaczny, Norbert E. Schindlbeck, K. Loeschke	1
3	»Dicke Bohnen« als Auslöser einer akuten hämolytischen Anämie 2008 ·DMW - Deutsche Medizinische Wochenschrift ·Rudolf L. Riepl, Jens Schreiner, Bettina Müller, Steven Hildemann, K. Loeschke	0
4	Screening for p53 and K-ras mutations in whole-gut lavage in chronic inflammatory bowel disease 2002 ·European Journal of Gastroenterology & Hepatology ·(unknown), Susanne Lang, (unknown), Max Reinshagen, J Emmrich, (unknown), Walter Heldwein, B. Wiebecke, K. Loeschke	15
5	Interferon-α-assoziierte Agranulozytose während Clozapin-Behandlung 2001 ·Der Nervenarzt ·Martin Schäfer, Folkhard Schmidt, Heinz Grunze, G. Laakmann, K. Loeschke	5
6	Adding Low-Dose Antidepressants to Interferon Alpha Treatment for Chronic Hepatitis C Improved Psychiatric Tolerability in a Patient with Schizoaffective Psychosis 2000 ·Neuropsychobiology ·Martin Schäfer, Folkhard Schmidt, Benedikt L. Amann, Stephan Schlösser, K. Loeschke, Heinz Grunze	28
7	Endothelial Cell Autoantibodies Are a Marker of Disease Susceptibility in Inflammatory Bowel Disease but Apparently Not Linked to Persistent Measles Virus Infection 2000 ·Clinical Immunology ·C Folwaczny, K. Loeschke, (unknown), Gundula Jäger, B. Wiebecke, Michael Höelscher, Tim Sauer, A. König, (unknown), Harald Fricke	13
8	Molecular screening of patients with long standing extensive ulcerative colitis: detection of p53 and Ki- ras mutations by single strand conformation polymorphism analysis and differential hybridisation in colonic lavage fluid 1999 ·Gut ·Susanna Lang, (unknown), (unknown), Walter Heldwein, B. Wiebecke, K. Loeschke	28
9	Lipid treatment of inflammatory bowel disease 1999 ·Current Opinion in Clinical Nutrition & Metabolic Care ·Stefan Endres, Reinhard Lorenz, K. Loeschke	30
10	Unfractioned Heparin in The Therapy of Patients With Highly Active Inflammatory Bowel Disease 1999 ·The American Journal of Gastroenterology ·C Folwaczny, B. Wiebecke, K. Loeschke	96
11	Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn’s disease 1998 ·Gut ·(unknown), Tilo Andus, K. W. Ecker, Andreas Raedler, K. Loeschke, Mathias Plauth, J. Rasenack, Alexander N.R. Weber, M Gierend, Klaus Ewe, J Schölmerich, (unknown)	80
12	Goblet cell autoantibodies in patients with inflammatory bowel disease and their first-degree relatives 1997 ·Gastroenterology ·C Folwaczny, (unknown), (unknown), (unknown), Walter Heldwein, K. Loeschke, Harald Fricke	59
13	N-3 fatty acids only delay early relapse of ulcerative colitis in remission 1996 ·Digestive Diseases and Sciences ·K. Loeschke, B. Ueberschaer, Angelika Pietsch, Elisabeth Gruber, Klaus Ewe, B. Wiebecke, Walter Heldwein, Reinhard Lorenz	92
14	Effects of a small bolus dose of ANF in healthy volunteers and in patients with volume retaining disorders 1990 ·Journal of Molecular Medicine ·J Heim, Kurt Gottmann, J. Weil, Helmut Schiffl, (unknown), K. Loeschke, R. Gerzer	9
15	Supplementation with n‐3 fatty acids from fish oil in chronic inflammatory bowel disease—a randomized, placebo‐controlled, double‐blind cross‐over trial 1989 ·Journal of Internal Medicine ·Reinhard Lorenz, Christian Weber, (unknown), Walter Heldwein, Thomas Strasser, K. Loeschke	152
16	Inhibition by loperamide of mucus secretion in the rat colon in vivo 1989 ·European Journal of Pharmacology ·K. Loeschke, Thomas E. Schmid, (unknown)	12
17	Discrepancy between effects of cholera toxin on net fluid movement and cAMP levels in rat jejunum, ileum, and colon 1988 ·Digestive Diseases and Sciences ·(unknown), R. Gerzer, Thérèse Keravis, K. Loeschke	7
18	Local Epinephrine Injection Improves the Therapeutic Effect of Nd-YAG Laser Treatment of Arterial Peptic Ulcer Bleeding 1988 ·Endoscopy ·Walter Heldwein, P. Lehnert, Stefan Martinoff, K. Loeschke	13
19	Effect of diphenolic laxatives on Na+-K+-activated ATPase and cyclic nucleotide content of rat colon mucosa in vivo 1980 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Jochen Schreiner, G. Nell, K. Loeschke	23
20	Chlorpropamide in diabetes insipidus. 1971 ·BMJ ·E. Uhlich, K. Loeschke	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact